UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051921
Receipt number R000058692
Scientific Title Impact of Periodontal Treatment on Clinical Outcomes in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Prospective Study (PERIO-PCI)
Date of disclosure of the study information 2023/09/01
Last modified on 2024/02/15 11:32:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of Periodontal Treatment on Clinical Outcomes in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Acronym

PERIO-PCI

Scientific Title

Impact of Periodontal Treatment on Clinical Outcomes in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Prospective Study (PERIO-PCI)

Scientific Title:Acronym

PERIO-PCI

Region

Japan


Condition

Condition

Coronary artery disease

Classification by specialty

Cardiology Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to prospectively examine if periodontal disease treatment can improve clinical outcomes in coronary artery disease patients undergoing percutaneous coronary intervention.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The composite endpoint that includes cardiovascular death, non-fatal myocardial infarction, target lesion revascularization, and non-target lesion revascularization at 24 months

Key secondary outcomes

Inflammatory markers at 12 months (high-sensitivity CRP, IL-6, TNF-alpha)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The study will target patients over 20 years of age with coronary artery disease (CAD) who undergo percutaneous catheter intervention (PCI) and who give informed consent to participate in this study. CAD includes stable angina as well as acute coronary syndromes (ACS) which consist of ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina.

Key exclusion criteria

1) Currently undergoing treatment for periodontal disease (PD)
2) Patients with cardiogenic shock, or hemodynamically or electrically unstable acute coronary syndrome (ACS)
3) Positive for COVID-19
4) Currently pregnant or breastfeeding
5) Carrying infectious diseases such as hepatitis virus or HIV.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Taishi
Middle name
Last name Yonetsu

Organization

Tokyo Medical and Dental University

Division name

Cardiology Division

Zip code

113-8510

Address

1 Chome-5-45 Yushima, Bunkyo City, Tokyo, Japan

TEL

+81-3-3813-6111

Email

t-yonetsu.cvm@tmd.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Araki

Organization

Tokyo Medical and Dental University

Division name

Cardiology Division

Zip code

113-8510

Address

1 Chome-5-45 Yushima, Bunkyo City, Tokyo, Japan

TEL

+81-3-3813-6111

Homepage URL


Email

maraki.cvm@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical and Dental University School of Medicine Ethics Review Board

Address

1 Chome-5-45 Yushima, Bunkyo City, Tokyo, Japan

Tel

+81-3-3813-6111

Email

syomu1.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 06 Month 27 Day

Date of IRB

2023 Year 06 Month 27 Day

Anticipated trial start date

2023 Year 09 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The following observational data collected from electronic medical records will be analyzed:

-Basic information of the research subjects
-General examination results
-Inflammatory markers
-Detail of Percutaneous coronary intervention
-Medications
-Cardiovascular events
-Periodontal disease evaluation


Management information

Registered date

2023 Year 08 Month 16 Day

Last modified on

2024 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058692